Zobrazeno 1 - 10
of 262
pro vyhledávání: ''
Autor:
Ke Wang, Lin Lei, Ji Peng, Jinrong Xiao, Guanzhong Lu, Sheng Wei, Jiao Huang, Yangkai Li, Ying Liu
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 11, Iss 1, Pp 281-294 (2022)
Cancer Medicine, Vol 11, Iss 1, Pp 281-294 (2022)
Background Lung cancer is the leading cause of cancer morbidity and mortality worldwide, however, the individualized treatment is still unsatisfactory. DNA methylation can affect gene regulation and may be one of the most valuable biomarkers in predi
Autor:
Li Pang, Zhiqiang Guo
Publikováno v:
Cancer Medicine, Vol 10, Iss 23, Pp 8558-8569 (2021)
Cancer Medicine
Cancer Medicine
Background There is currently no recognized first‐line treatment strategy for ovarian neuroendocrine tumors (NETs). Furthermore, because of the low incidence of ovarian NETs, no studies have reported prognostic statistics derived from large samples
Autor:
Jinyi Wang, Guohan Chen, Guangxue Wang, Xuan Hong, Zhiyuan Huang, Tian Zhao, Yejun Cao, Qiying Zhang, Zhengjun Chai, Jie Liu, Qinchuan Li, Yang Han, Zhengliang Sun
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 11, Iss 2, Pp 348-357 (2022)
Cancer Medicine, Vol 11, Iss 2, Pp 348-357 (2022)
Objective The aim of this study was to assess the efficacy and safety of intrapleural perfusion with hyperthermic chemotherapy (IPHC) in treating malignant pleural effusion (MPE) compared to normothermic chemoperfusion of the pleural cavity (NCPC), a
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 24, Pp 8934-8943 (2021)
Cancer Medicine, Vol 10, Iss 24, Pp 8934-8943 (2021)
Background Many real‐world studies of patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) are restricted to single centers, limiting the generalizability of their insights. This study aimed to identify important population‐based pre
Autor:
Tetsuya Fukumoto, Naoya Sugihara, Kenichi Nishimura, Noriyoshi Miura, Yuki Miyauchi, Ryuta Watanabe, Yuichiro Sawada, Takashi Saika, Keisuke Funaki, Tadahiko Kikugawa, Kanae Koyama, Toshio Kakuda, Terutaka Noda
Publikováno v:
Cancer Medicine, Vol 10, Iss 22, Pp 7968-7976 (2021)
Cancer Medicine
Cancer Medicine
Background Patients with very‐high‐risk prostate cancer (VHRPCa) have earlier biochemical recurrences (BCRs) and higher mortality rates. It remains unknown whether extended robot‐assisted laparoscopic prostatectomy (eRALP) without neoadjuvant o
Autor:
Eiji Shinozaki, Hiroki Osumi, Mariko Ogura, Keisho Chin, Kensei Yamaguchi, Izuma Nakayama, Daisaku Kamiimabeppu, Takeru Wakatsuki, Keitaro Shimozaki, Daisuke Takahari, Akira Ooki
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 24, Pp 8820-8828 (2021)
Cancer Medicine, Vol 10, Iss 24, Pp 8820-8828 (2021)
Background Circulating tumor DNA (ctDNA) is a biomarker with potential to reflect comprehensive genomic information and overcome intratumor heterogeneity. In contrast, carcinoembryonic antigen (CEA) is a conventional tumor marker for predicting recur
Autor:
Isaac E. Kim, Monish Aron, Thomas L. Jang, Daniel D. Kim, Saum Ghodoussipour, Mark N. Stein, Isaac Yi Kim, David Y. Lee, Marc A. Dall'Era, Eric A. Singer, Sinae Kim
Publikováno v:
Cancer Medicine, Vol 10, Iss 22, Pp 7909-7920 (2021)
Cancer Medicine
Cancer Medicine
Since 2004, multiple blockbuster drugs have been approved for men with metastatic prostate cancer. Nevertheless, it has been reported that no improvement in survival was observed between 2004 and 2009. Herein, we have analyzed the SEER database to as
Autor:
Linlin Ji, Xiao-Bei Mao, Mengxi Huang, Dan Xiang, Gongbo Fu, Siqi Sheng, Xiaoyuan Chu, Jiani Guo, Jialong Zhu, Shuai Hao, Yadi Huang, Zengjie Lei
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 23, Pp 8708-8719 (2021)
Cancer Medicine, Vol 10, Iss 23, Pp 8708-8719 (2021)
Background Some significant differences exist between the outcomes of left‐ and right‐sided colon cancer patients. The presence of nodal metastases is a critical prognostic factor, especially in the absence of distant metastasis. Our research stu
Autor:
Xinchao Liu, Zhaoqin Huang, Fei Ren, Kaikai Zhao, Xiangjiao Meng, Jinming Yu, Yao Wang, Yu Chen
Publikováno v:
Cancer Medicine, Vol 10, Iss 23, Pp 8518-8529 (2021)
Cancer Medicine
Cancer Medicine
Background The safety of thoracic radiotherapy (TRT) after programmed death 1/programmed death ligand 1 (PD‐(L)1) inhibitor treatment in patients with lung cancer was scarcely reported. This retrospective study was conducted to evaluate the inciden
Autor:
Zongbi Yi, Shune Yang, Fengzhu Guo, Hui Li, Yuee Teng, Wenna Wang, Shusen Wang, Pei Yu, Xinlan Liu, Runxiang Yang, Quchang Ouyang, Yongmei Yin, Hongyuan Li, Xichun Hu, Zhongsheng Tong, Huawei Yang, Tao Sun, Jiayu Wang, Li Cai, Yiqun Han, Min Yan, Zefei Jiang, Binghe Xu, Xiaojia Wang, Xi Chen, You-Lin Qiao, Tao Huang, Jin-Hu Fan, Jianjun He, Su Zhang
Publikováno v:
Cancer Medicine, Vol 10, Iss 19, Pp 6744-6761 (2021)
Cancer Medicine
Cancer Medicine
Background Anthracycline‐based chemotherapy (ABC) is one of the standard therapies against breast cancer. However, few guidelines are currently available to optimize the use of ABC. Therefore, the present analysis aimed at determining the profile a